Pages that link to "Q35208654"

The following pages link to Targeting the HER/EGFR/ErbB family to prevent breast cancer. (Q35208654):

Displaying 41 items.

• PEA-15 facilitates EGFR dephosphorylation via ERK sequestration at increased ER-PM contacts in TNBC cells (Q24323230) (← links)
• Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies (Q34158454) (← links)
• Assay of lapatinib in murine models of cigarette smoke carcinogenesis. (Q34260243) (← links)
• CDK7-dependent transcriptional addiction in triple-negative breast cancer. (Q34495729) (← links)
• RNA-Seq of human breast ductal carcinoma in situ models reveals aldehyde dehydrogenase isoform 5A1 as a novel potential target (Q34510318) (← links)
• Automated analysis of immunohistochemistry images identifies candidate location biomarkers for cancers (Q34793009) (← links)
• RTK/ERK pathway under natural selection associated with prostate cancer (Q35040853) (← links)
• In Utero exposure to low-dose alcohol induces reprogramming of mammary development and tumor risk in MMTV-erbB-2 transgenic mice (Q35585536) (← links)
• Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ. (Q35663802) (← links)
• A critical role for HER3 in HER2-amplified and non-amplified breast cancers: function of a kinase-dead RTK. (Q35682599) (← links)
• Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy (Q35851983) (← links)
• miR-sc8 Inhibits Schwann Cell Proliferation and Migration by Targeting Egfr (Q35873039) (← links)
• Salivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression (Q35909258) (← links)
• Animal models for exploring the pharmacokinetics of breast cancer therapies (Q36093956) (← links)
• HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis (Q36106546) (← links)
• Targeting HER2 Positive Breast Cancer with Chemopreventive Agents (Q36114852) (← links)
• DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3. (Q36203244) (← links)
• Role of ErbB Receptors in Cancer Cell Migration and Invasion (Q36311027) (← links)
• Endocrine resistance in breast cancer--An overview and update (Q36386322) (← links)
• Preclinical HER-2 Vaccines: From Rodent to Human HER-2 (Q36914661) (← links)
• HER3 is required for HER2-induced preneoplastic changes to the breast epithelium and tumor formation. (Q36957145) (← links)
• Chemoprevention of Breast Cancer: The Paradox of Evidence versus Advocacy Inaction (Q37017096) (← links)
• Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer (Q37125328) (← links)
• Clinical applications of mouse models for breast cancer engaging HER2/neu (Q37607675) (← links)
• N-Methyl-N-nitrosourea as a mammary carcinogenic agent. (Q38589651) (← links)
• Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer (Q38940200) (← links)
• Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway (Q39016174) (← links)
• Network-based pathway enrichment analysis with incomplete network information (Q39644743) (← links)
• Breast reconstruction with autologous fat graft; does platelet-rich plasma affect patient's survival? (Q41891665) (← links)
• The GDNF Family: A Role in Cancer? (Q47137356) (← links)
• Targeted Therapies Against Growth Factor Signaling in Breast Cancer (Q47559665) (← links)
• Conditional expression of Ki-RasG12V in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma (Q48026385) (← links)
• Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF‑7 cells in vitro and in vivo and its mechanism of action (Q49378719) (← links)
• Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ. (Q50592584) (← links)
• An intermittent approach for cancer chemoprevention (Q51662524) (← links)
• Traditional Chinese Medicine CFF-1 induced cell growth inhibition, autophagy, and apoptosis via inhibiting EGFR-related pathways in prostate cancer. (Q52658477) (← links)
• Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features (Q57181580) (← links)
• Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth (Q58728275) (← links)
• A Bioinformatics Approach for Understanding Genotype–Phenotype Correlation in Breast Cancer (Q62669600) (← links)
• Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy (Q90245486) (← links)
• Quantification of EGFR family in canine mammary ductal carcinomas in situ: implications on the histological graduation (Q90291834) (← links)